Purple Biotech Stock Market Value
| PPBT Stock | USD 3.36 0.05 1.47% |
| Symbol | Purple |
Purple Biotech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Purple Biotech. If investors know Purple will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Purple Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Purple Biotech is measured differently than its book value, which is the value of Purple that is recorded on the company's balance sheet. Investors also form their own opinion of Purple Biotech's value that differs from its market value or its book value, called intrinsic value, which is Purple Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Purple Biotech's market value can be influenced by many factors that don't directly affect Purple Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Purple Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Purple Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Purple Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Purple Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Purple Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Purple Biotech.
| 01/01/2025 |
| 01/31/2025 |
If you would invest 0.00 in Purple Biotech on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Purple Biotech or generate 0.0% return on investment in Purple Biotech over 30 days. Purple Biotech is related to or competes with Pluri, BioLineRx, Enlivex Therapeutics, Anebulo Pharmaceuticals, Pmv Pharmaceuticals, Bio Path, and Cingulate. Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug... More
Purple Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Purple Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Purple Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.15 | |||
| Information Ratio | 0.0322 | |||
| Maximum Drawdown | 176.64 | |||
| Value At Risk | (17.01) | |||
| Potential Upside | 17.25 |
Purple Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Purple Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Purple Biotech's standard deviation. In reality, there are many statistical measures that can use Purple Biotech historical prices to predict the future Purple Biotech's volatility.| Risk Adjusted Performance | 0.0405 | |||
| Jensen Alpha | 0.6663 | |||
| Total Risk Alpha | (1.47) | |||
| Sortino Ratio | 0.0728 | |||
| Treynor Ratio | 0.7585 |
Purple Biotech Backtested Returns
Purple Biotech is very risky given 3 months investment horizon. Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0735, which implies the firm had a 0.0735 % return per unit of risk over the last 3 months. We have analyzed twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.58% are justified by taking the suggested risk. Use Purple Biotech Semi Deviation of 8.56, coefficient of variation of 2699.63, and Risk Adjusted Performance of 0.0405 to evaluate company specific risk that cannot be diversified away. Purple Biotech holds a performance score of 5 on a scale of zero to a hundred. The company holds a Beta of 1.0, which implies possible diversification benefits within a given portfolio. Purple Biotech returns are very sensitive to returns on the market. As the market goes up or down, Purple Biotech is expected to follow. Use Purple Biotech potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on Purple Biotech.
Auto-correlation | 0.60 |
Good predictability
Purple Biotech has good predictability. Overlapping area represents the amount of predictability between Purple Biotech time series from 1st of January 2025 to 16th of January 2025 and 16th of January 2025 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Purple Biotech price movement. The serial correlation of 0.6 indicates that roughly 60.0% of current Purple Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.6 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Purple Biotech lagged returns against current returns
Autocorrelation, which is Purple Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Purple Biotech's stock expected returns. We can calculate the autocorrelation of Purple Biotech returns to help us make a trade decision. For example, suppose you find that Purple Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Purple Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Purple Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Purple Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Purple Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Purple Biotech Lagged Returns
When evaluating Purple Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Purple Biotech stock have on its future price. Purple Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Purple Biotech autocorrelation shows the relationship between Purple Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Purple Biotech.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.